I feel very confident this conversation has happened before. Would you be able to look up how much those options were worth the last time you mentioned them? My guess is, it was close to triple what they are worth today. If I remember correctly they were granted at below the share price at inception. What would you charge to loan Cellceutix two million dollars with their current situation having completed four clinical trials successfully? What would you have charged them at the state of development when that loan was originated. My bet is your terms would have been far in excess of the ones granted. Isn't a large part of their present value due to the efforts of the CEO in progressing the company's pipeline?
Market Data 
Markets 
AI
